Page 40 - உயிரி தொழில்நுட்பவியல் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PARIS and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) Biophytis (Euronext Growth Paris: ALBPS) (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, announces today that trading of its ordinary shares and share warrants on Euronext Growth will be temporarily halted at the Company’s request from the opening of the market at 9 a.m. CET in the context of its initial public offering on the Nasdaq Capital Market in order to allow for the confirmation of allocations to investors and for the commencement of trading of the Company’s American Depositary Shares (ADSs) on the Nasdaq Capital Market. This trading halt will remain effective until a new communication is released by

Helvetica neueYahoo holdings incInitial public offeringNasdaq capital marketThe companyBiotechnology companyForward looking statementsForward looking statementEuronext growthFunctional outcomesPublic offeringProduct developmentயாகூ ஹோல்டிங்ஸ் இன்க்ஆரம்ப பொது பிரசாதம்நாஸ்டாக் மூலதனம் சந்தைதி நிறுவனம்